The FDA and Vaginal mesh
In older women use of a vaginal mesh implant was thought to be an efficient method of repairing severe pelvic organ prolapse – which occurs when pelvic organs fall out of place — than just by stitching the connective tissue in the vaginal wall muscle back together, was the finding of a study in May 2011.
It is known that POP repair comes with a high rate of serious adverse results from the operation, such as bladder perforation and pelvic hemorrhage when normally done because of the danger and sensitivity of the organs involved. These adverse events after the procedure, including new urinary incontinence and pain at the time of sex are common, according to the study. This is a complex procedure and the study claimed that the success rate using vaginal mesh was significantly higher than just stitching up.
But the FDA disagrees with the conclusion of that study. In July 2011 they issued a Vaginal Mesh FDA Warning which concluded amongst other things that there was little evidence to suggest that the results from a mesh implant were significantly better than the traditional operation where normal sutures were used.
The difficulty with mesh procedures are that operation in the pelvic floor is very complicated already. The surgeon is dealing with a plenty of organs all very close together and with the older muscles lengthened or diminished there is always a danger of piercing something else while doing sutures.
Pelvic organ prolapse occurs when the pelvic organs, such as the bladder and urethra, drop downward, often since of a weakness in the vaginal wall associated with childbirth, hysterectomy or menopause. This can cause the vagina to push forward, causing irritation and even incontinence. The standard procedure is to start conservatively with prescribing particular exercises, then a pessary. Only if operation is essential for repairing a pelvic organ prolapse is stitching together the area of connective tissue (fascia) where the muscles own diminished. The transvaginal mesh procedure — involves using a piece of synthetic mesh that has what looks like wings to anchor the mesh. These are pushed deeper into the connective tissue, anchoring it more securely, and then stitched into place.
After the 2008 FDA sign it was recommended that physicians obtain specialized training in placing the mesh, that they watch patients meticulously for signs of contagion or corrosion of the fascia around the mesh, and that they fully inform their patients of all potential problems. What is manifesting itself now is that additional failures are being reported which has led to the FDA bulletin on 13 July 2011 and the meeting between the FDA and the manufacturers on 9 September 2011.
In the meantime certain 500 Lawsuits have been opened as a mass tort against the manufacturers. Since the 2008 and the 2011 warnings over 2,000 reported cases of Vaginal Mesh complications which the FDA believes to be understated. Anybody who has had the mesh implanted ought sustain their regime of annual checkups if they are not experiencing any problems.. This group must be greater than 98% of all women who possess had mesh implants. Any others (the less than 2%) who are experiencing irritation or pain should get in touch with a Vaginal Mesh Lawyer.